In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...

Allan Coukell, chief government affairs officer at Civica, said manufacturing has begun at the company's new pharmaceutical plant in Virginia but there is no timeline for when the first insulin -- a ...

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

Snapshot of the implementation used to generate figures and numerical results from the paper "Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved ...

Sanofi has announced it is going to invest €44 million on its site in Waterford, Ireland, in order to boost production of its top-selling insulin, Lantus. The Waterford site is currently the ...